Fluoxetine increases norepinephrine release in rat hypothalamus as measured by tissue levels of MHPG-SO4 and microdialysis in conscious rats

Journal of Neural Transmission
K W Perry, R W Fuller

Abstract

The selective serotonin uptake inhibitor fluoxetine (10 mg/kg i.p.) increased tissue levels of the norepinephrine metabolite 3-methoxy-4-hydroxyphenylethylene glycol sulfate (MHPG-SO4) in rat hypothalamus, indicating an increased release of norepinephrine. Microdialysis studies in conscious rats showed that fluoxetine (10 mg/kg i.p.) increased extracellular concentrations of norepinephrine as well as serotonin in the hypothalamus. In contrast, desipramine (10 mg/kg i.p.) increased extracellular concentration of norepinephrine but not serotonin in the hypothalamus. Consistent with its mechanism of being a selective serotonin uptake inhibitor, local perfusion of fluoxetine (10 microM) caused a 7-fold increase in hypothalamic extracellular serotonin and a small non-significant increase in extracellular norepinephrine. The subsequent systemic injection of fluoxetine (10 mg/kg s.c.) after local perfusion caused a 3-fold increase in extracellular norepinephrine, indicating that fluoxetine's action leading to an increase in extracellular norepinephrine was not occurring in the terminal areas of the hypothalamus but elsewhere in the brain, possibly cell bodies in the locus coeruleus.

References

Mar 1, 1978·The Journal of Comparative Neurology·J M Cedarbaum, G K Aghajanian
Dec 1, 1975·European Journal of Pharmacology·G CalderiniS Garattini
Sep 23, 1986·European Journal of Pharmacology·S Hjorth, A Carlsson
Oct 1, 1986·Physiology & Behavior·J P Kroon, A L Riley
Jul 1, 1986·Naunyn-Schmiedeberg's Archives of Pharmacology·T J Feuerstein, G Hertting
Dec 1, 1993·Pharmacology, Biochemistry, and Behavior·X Paez, S F Leibowitz

❮ Previous
Next ❯

Citations

Mar 10, 2012·Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine·Tierney A Lorenz, Cindy M Meston
Jul 27, 1999·Pharmacology, Biochemistry, and Behavior·J C WinterR A Rabin
May 19, 2000·Neuroreport·S Puglisi-AllegraV Romano
Mar 3, 2005·Neuropsychobiology·Patrizia BlardiPaolo Castrogiovanni
Jan 1, 2001·International Journal of Psychiatry in Clinical Practice·J G Rahola
Oct 28, 2008·Stress : the International Journal on the Biology of Stress·Christopher A LowryCliff H Summers
Apr 18, 2014·Expert Opinion on Drug Discovery·Laura Perez-CaballeroEsther Berrocoso
Aug 9, 2011·Metabolism: Clinical and Experimental·Min Jung ParkGregory G Freund
Apr 2, 2005·Synapse·Luciano MinuzziPaul Cumming
May 26, 2004·Biological Psychiatry·Matthew A SeagerKurt Rasmussen
Jun 7, 2006·European Journal of Pharmacology·Hideki Arimochi, Kyoji Morita
Apr 29, 2016·Journal of Psychiatric Practice·Ahmed NaguyAli Al-Tajali
Oct 22, 2008·Chemico-biological Interactions·Ilhami Gülçin
Apr 14, 2017·Bioscience, Biotechnology, and Biochemistry·Pirzada Jamal Ahmed SiddiquiAhsana Dar
Mar 15, 2003·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Mihály HajósEva Hajós-Korcsok
Apr 20, 2016·Proceedings of the National Academy of Sciences of the United States of America·Manqi WangMatthew D Whim
Jul 20, 2002·The Journal of Pharmacology and Experimental Therapeutics·Alicia M Crissman, James M O'Donnell
Aug 17, 2002·The Journal of Pharmacology and Experimental Therapeutics·Steven T Szabo, Pierre Blier
Jul 3, 2004·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Eleni T TzavaraGeorge G Nomikos
Apr 4, 2006·Neuroscience and Behavioral Physiology·G T ShishkinaL V Anikina

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.